| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/31/2007 | WO2007016525A3 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 05/31/2007 | WO2007013896A3 Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors |
| 05/31/2007 | WO2007001385A3 Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
| 05/31/2007 | WO2006098852A3 Hydroxyalkyl substituted imidazoquinolines |
| 05/31/2007 | WO2006091568A3 Hydroxyalkyl substituted imidazonaphthyridines |
| 05/31/2007 | WO2006091567A3 Hydroxyalkyl substituted imidazoquinoline compounds and methods |
| 05/31/2007 | WO2006004937A3 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 05/31/2007 | WO2005099688A3 Cyclic compounds |
| 05/31/2007 | US20070124152 Hiv Integrase Inhibitors |
| 05/31/2007 | US20070123561 Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors |
| 05/31/2007 | US20070123560 Dehalogeno-compounds |
| 05/31/2007 | US20070123553 Aryl imidazoles and their use as anti-cancer agents |
| 05/31/2007 | US20070123552 Method of manufacturing of 7-ethyl-10-hydroxycamptotecin |
| 05/31/2007 | US20070123535 3-Amino-1-arylpropyl azaindoles and uses thereof |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123529 Substituted biphenyl compounds |
| 05/31/2007 | US20070123522 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/31/2007 | US20070123507 Process for converting heterocyclic ketones to amido-substituted heterocycles |
| 05/31/2007 | US20070123381 Wheel drive |
| 05/31/2007 | US20070119000 Cationic naphthalene dyes and colorants for keratin fibers, particularly human hair; 4-{(E)-[(1,3-diketo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)imino]methyl}-1-(2-hydroxyethyl)pyridinium bromide, for example |
| 05/31/2007 | DE102005049954A1 Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 05/31/2007 | CA2630907A1 Pyrazoloisoquinoline derivatives |
| 05/31/2007 | CA2630617A1 Compositions and methods for modulating gated ion channels |
| 05/31/2007 | CA2629738A1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same |
| 05/31/2007 | CA2629512A1 Bicyclic cinnamide compound and prophylactic or therapeutic uses thereof |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790650A1 Novel substituted imidazole derivatives |
| 05/30/2007 | EP1790649A1 Substituted bicyclic pyrimidone derivatives |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790342A1 Pyridopyrazine derivatives and their use as signal transduction modulators |
| 05/30/2007 | EP1789419A1 Gyrase inhibitors and uses thereof |
| 05/30/2007 | EP1789415A1 Method for producing quaterrylene-3,4:13,14-tetracarboxy diimides by direct synthesis |
| 05/30/2007 | EP1789409A2 Sulfonamides and uses thereof |
| 05/30/2007 | EP1789399A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789042A2 1-alkoxy 1h-imidazo ring systems and methods |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972944A Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 05/30/2007 | CN1972943A New derivatives of 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxamide or 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxylic acid |
| 05/30/2007 | CN1972942A Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 05/30/2007 | CN1972941A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists |
| 05/30/2007 | CN1972940A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
| 05/30/2007 | CN1972939A Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content |
| 05/30/2007 | CN1972938A 环状胺化合物 Cyclic amine compound |
| 05/30/2007 | CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 05/30/2007 | CN1970559A Beta-carboline alkaloid, their preparation method and use |
| 05/30/2007 | CN1318424C Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318421C Non-nucleoside reverse transcriptase inhibitors |
| 05/30/2007 | CN1318420C Dipyridodiazepinones as reverse transcriptase inhibitors |
| 05/30/2007 | CN1318419C 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides |
| 05/29/2007 | US7223866 Imidazo[1,5-a]pyridine derivatives and methods for treating aldosterone mediated diseases |
| 05/29/2007 | US7223776 Compounds with anti-bacterial activity |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223768 Fused ring heterocycles as potassium channel modulators |
| 05/29/2007 | US7223753 Diazabicyclic biaryl derivatives |
| 05/29/2007 | US7223752 Biphenyl vasopressin agonists |
| 05/29/2007 | US7223750 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/24/2007 | WO2007059219A1 Azaindazoles useful as inhibitors of kinases |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007057775A1 Spiropiperidine derivatives |
| 05/24/2007 | WO2007057329A1 Azaindole-2-carboxamide derivatives |
| 05/24/2007 | WO2007006566A8 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 05/24/2007 | WO2007006533A3 Indolylmaleimide derivatives |
| 05/24/2007 | US20070117850 substituted or unsubstituted 2-pyridyl moiety and a pyrozole ring substituted at 4 position with pyridine ring; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117824 Spirocyclic compounds |
| 05/24/2007 | US20070117816 Kinase inhibitors |
| 05/24/2007 | US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 05/24/2007 | US20070117795 Methods and compositions of novel triazine compounds |
| 05/24/2007 | US20070117786 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
| 05/24/2007 | CA2630360A1 Substituted bicyclic pyrimidone derivatives |
| 05/24/2007 | CA2629314A1 Tec kinase inhibitors |
| 05/24/2007 | CA2629232A1 Azaindole-2-carboxamide derivatives |
| 05/24/2007 | CA2628179A1 Azaindazoles useful as inhibitors of kinases |
| 05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/23/2007 | EP1787991A1 PYRROLOÝ2,3-c¨PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 05/23/2007 | EP1786822A1 Fused tricyclic derivatives for the treatment of psychotic disorders |
| 05/23/2007 | EP1786816A1 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 05/23/2007 | EP1786815A1 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 05/23/2007 | EP1786814A1 Bicyclononene derivatives as renin inhibitors |
| 05/23/2007 | EP1786813A2 Bicyclic heteroaryl pde4b inhibitors |
| 05/23/2007 | EP1786812A1 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 05/23/2007 | EP1786811A2 Triazolopyridine compounds |
| 05/23/2007 | EP1786807A1 Heterocyclic antiviral compounds |
| 05/23/2007 | EP1786803A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
| 05/23/2007 | EP1786802A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
| 05/23/2007 | EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 05/23/2007 | EP1786774A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2007 | EP1651641B1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/23/2007 | EP1625127B1 Azaindole compounds as kinase inhibitors |
| 05/23/2007 | EP1442040B1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | CN1968955A Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 05/23/2007 | CN1968952A New indazole and indolone derivatives and their use pharmaceuticals |